0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Economics, Pharma, Policy and politics 8/21/12 Economics, Pharma, Policy and politics 8/21/12

Rerun: Two views on the Avastin/Lucentis debate

Read More
Culture, Economics, Pharma 8/20/12 Culture, Economics, Pharma 8/20/12

Rerun: Are prescription drugs going the way of Napster, YouTube and iTunes?

Read More
Culture, Pharma, Physicians 7/5/12 Culture, Pharma, Physicians 7/5/12

Rerun: What the Talmud teaches about drug company gifts to doctors

Read More
Pharma, Research 7/2/12 Pharma, Research 7/2/12

Rerun: Are women getting crazier? Medco seems to think so

Read More
Economics, Pharma 6/21/12 Economics, Pharma 6/21/12

Did pharma reps win by losing their overtime pay lawsuit?

Read More
Economics, Pharma 4/19/12 Economics, Pharma 4/19/12

SXC-Catalyst merger: Would have been surprising if it hadn't happened

Read More
Pharma, Research 3/20/12 Pharma, Research 3/20/12

Are women getting crazier? Medco seems to think so

Read More
Pharma, Research 2/13/12 Pharma, Research 2/13/12

Personalized medicine for the brain. A discussion with Brain Resource’s Evian Gordon (transcript)

Read More
Pharma, Policy and politics 2/2/12 Pharma, Policy and politics 2/2/12

Time for FDA to hire some pharma marketers?

Read More
Pharma, Research 1/30/12 Pharma, Research 1/30/12

Personalized medicine for the brain. A discussion with Brain Resource's Evian Gordon

Read More
Pharma 1/18/12 Pharma 1/18/12

What to make of the "That's What PBMs Do" PR campaign

Read More
Culture, Pharma, Policy and politics 1/12/12 Culture, Pharma, Policy and politics 1/12/12

Oxycontin and heroin addiction. Business opportunities in the push to address the problem

Read More
Pharma 1/11/12 Pharma 1/11/12

Why does some "pure" vanilla contain corn syrup or sugar?

Read More
Economics, Pharma 12/20/11 Economics, Pharma 12/20/11

Sorry Lipitor, you're no match for generics

Read More
Economics, Patients, Pharma 12/9/11 Economics, Patients, Pharma 12/9/11

Will pharma risk-sharing work better when the patient is the customer?

Read More
Economics, Hospitals, Pharma, Policy and politics 12/7/11 Economics, Hospitals, Pharma, Policy and politics 12/7/11

Schumer's completely unhelpful approach to curbing drug shortages

Read More
Pharma, Policy and politics 12/1/11 Pharma, Policy and politics 12/1/11

Avastin denial for breast cancer: the right thing even if the Wall Street Journal doesn't think so

Read More
Announcements, Pharma, Policy and politics 11/18/11 Announcements, Pharma, Policy and politics 11/18/11

I'm quoted on Marketplace re: Avastin

Read More
Pharma, Policy and politics 11/18/11 Pharma, Policy and politics 11/18/11

Yanking Avastin's breast cancer indication --the right thing to do

Read More
Health plans, Patients, Pharma, Physicians, Policy and politics 11/3/11 Health plans, Patients, Pharma, Physicians, Policy and politics 11/3/11

Off-label drug promotion and the First Amendment

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.